Navigation Links
Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis

d with significant mortality (2), was reduced by 41 percent. Additionally, the reduction in spine fractures was sustained over three years (60 percent in year one, 71 percent in year two, and 70 percent in year three).

"We believe Reclast is an innovative treatment approach for the millions of women with osteoporosis and provides impressive fracture reduction, the primary goal of osteoporosis treatment," said James Shannon, MD, Global Head of Development at Novartis Pharma AG.

About the Pivotal Fracture Trial

The Pivotal Fracture Trial was a Phase III, multi-center, randomized, placebo-controlled study examining the efficacy and safety of Reclast in reducing the risk of bone fracture in women with postmenopausal osteoporosis. The study enrolled more than 7,700 women between the ages of 65 and 89 with postmenopausal osteoporosis in 27 countries. The primary endpoints of the study were new spine and hip fractures over three years compared to placebo. Secondary endpoints included reducing the incidence of non-spine fractures, evaluation of bone mineral density (BMD), normalization of bone turnover markers, and overall safety.

In addition to reductions in spine and hip fractures, the study also demonstrated that Reclast significantly reduced the risk of non-spine, all clinical, and clinical spine fractures by 25 percent, 33 percent and 77 percent respectively.

Bone mineral density increased significantly in the spine by 6.7 percent and the hip by 6 percent in women on Reclast compared to placebo.

In the study, overall incidence of adverse events experienced with Reclast was comparable to placebo. The most common post-dose adverse events with Reclast were fever, muscle pain, flu-like symptoms, headache, and joint pain, most of which occurred within the first three days following Reclast administration. The majority of these symptoms resolved within three days of the event onset. The incidence decreased markedly with subsequent an
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
5. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
6. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
7. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
8. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
9. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
10. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
11. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants

Post Your Comments:
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...arch report is available in its catalogue: ,, ...orecasts to 2015 ,, http://www.reportlinker.c...alysis-and-Forecasts-to-2015.html ,, United St...to 2015 ,, Summary ,, This report is an es...
(Date:11/25/2009)..., , UNION CITY, Calif., Nov. 25 /PRNewswire-...ical products company manufacturing point-of-care ... Severson, chairman and chief executive officer, w...h Care Conference on Wednesday, December 2, 2009 a... New York Palace Hotel in New York City. ,, Ab...
(Date:11/25/2009)..., , WALTHAM, Mass., Nov. 25 /PRNewswi...), the global authority on medical technology mark...or trauma fixation devices will continue to see ra...cent economic slowdown. MRG,s US Markets for Trau...ill remain highly dynamic over the next five years...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Nationally Known Psychotherapist Dr Robi Ludwig Joins Qualsecs Wholly Owned Subsidiary VitaminSpice 60711 1Nationally Known Psychotherapist Dr Robi Ludwig Joins Qualsecs Wholly Owned Subsidiary VitaminSpice 60711 2Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 1Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 2Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 3Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 4Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 5Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 6Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 7Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 8Dialysis Corporation of America Reports Third Quarter 2009 Results 60708 9Service Corporation International Announces Third Quarter 2009 Financial Results 60705 1Service Corporation International Announces Third Quarter 2009 Financial Results 60705 2Service Corporation International Announces Third Quarter 2009 Financial Results 60705 3Service Corporation International Announces Third Quarter 2009 Financial Results 60705 4Service Corporation International Announces Third Quarter 2009 Financial Results 60705 5Service Corporation International Announces Third Quarter 2009 Financial Results 60705 6Service Corporation International Announces Third Quarter 2009 Financial Results 60705 7Service Corporation International Announces Third Quarter 2009 Financial Results 60705 8Service Corporation International Announces Third Quarter 2009 Financial Results 60705 9Service Corporation International Announces Third Quarter 2009 Financial Results 60705 10Service Corporation International Announces Third Quarter 2009 Financial Results 60705 11Service Corporation International Announces Third Quarter 2009 Financial Results 60705 12Service Corporation International Announces Third Quarter 2009 Financial Results 60705 13Service Corporation International Announces Third Quarter 2009 Financial Results 60705 14Service Corporation International Announces Third Quarter 2009 Financial Results 60705 15Service Corporation International Announces Third Quarter 2009 Financial Results 60705 16Service Corporation International Announces Third Quarter 2009 Financial Results 60705 17Service Corporation International Announces Third Quarter 2009 Financial Results 60705 18Service Corporation International Announces Third Quarter 2009 Financial Results 60705 19Service Corporation International Announces Third Quarter 2009 Financial Results 60705 20Service Corporation International Announces Third Quarter 2009 Financial Results 60705 21Service Corporation International Announces Third Quarter 2009 Financial Results 60705 22Service Corporation International Announces Third Quarter 2009 Financial Results 60705 23Service Corporation International Announces Third Quarter 2009 Financial Results 60705 24Service Corporation International Announces Third Quarter 2009 Financial Results 60705 25
.... 17 Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV...ble letter from the U.S. Food and Drug Administrat...ion of valrubicin for intravesical,instillation, i... of,bacillus Calmette-Guerin (BCG)-refractory carc...AR was removed from the market in 2002 due to impu...
.... 17 AutoGenomics, a leader in,developing automat...at its,CYP450 2C9-VKORC1 panel that it submitted t... now been evaluated by the Harvard Medical,School-...cs (HPCGG). Warfarin (also called Coumadin) is a ...more than 2 million prescriptions per year, one of...
Other Medicine Technology:Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 2Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 3Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 4Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity 2
(Date:11/27/2009)...ewswire-FirstCall/ -- The Gymboree Corporation (Na...O, will present at the NASDAQ OMX 23rd Investor Pr... London, England, on Wednesday, December 2, 2009, ...cast of The Gymboree Corporation,s presentation ov..., click on "Our Company" at the bottom of the page...
(Date:11/27/2009)...dings has announced that it has become a national ...rgest nonprofit organizations dedicated to arthrit... Delray Beach, FL (Vocus) Novembe...), a company specializing in the marketing and ret...has announced today that is has become a national ...
(Date:11/27/2009)...h™ announced today that Spectrum Health (Gra...terprise orthopedic templating solution and its Tr... (PRWEB) November 27, 2009 -- Voyant Hea...rand Rapids, Michigan) has licensed its TraumaCad ...TraumaCad Extend workflow solution, to allow its o...
(Date:11/26/2009)...ire/ -- With cold and flu season upon us, it,s mor...control the spread of infections and avoid illness...ourselves healthy, but to avoid transmitting illne...C (certified in infection-control), nursing direct...t Hospital for Special Surgery (HSS) in Manhattan....
(Date:11/26/2009)...n lead to strains or worse , , THURSDAY,...wrong with stuffing your turkey full to bursting, ...our suitcase as you pack for holiday trips. , M.... hospital emergency rooms, doctors, offices, clin...ed injuries, such as muscle strains, pulls and tea...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2
...., April 7, 2008 Penn Foster Career School,now of... essential skills,for working professionals. The p...ficate programs such as:, -- Anatomy and Physiolo...irst aid technicians can learn the basics of the b...
..., April 7, 2008 Schoolchildren,who required surge...un a,significant risk of having problems with inat...ial services in school. "These children are at ris...eening," said study leader Amanda J. Shillingford,...
..., April 7, 2008 The Children,s,Hospital of Philad... the,Autism Genetic Resource Exchange (AGRE), a sc..., dedicated to advancing genetic research in,autis... employs highly,automated microarray technology to...
...ys may not only play a central role in the develop..., but also in much more common acquired chronic lu...igarette smoke-induced chronic obstructive pulmona...s Mall from the Department of Pediatrics at Heidel...
...opment of the eye in mammals (and this naturally i...ess beginning in an early embryonic phase. The sam... elastic and transparent lenses, which focus light...lt, a pin sharp image is created on the retina. As...
...lity Lets Disabled Middle Island Man Enjoy His You...pril 7, 2008 After,terrorists attacked the World ...Patrolman Kevin O,Connor was dispatched to help at...d later in,the line of duty., At 32, Mr. O,Connor...
Other Medicine News:Health News:Penn Foster Career School Offers Certificate Programs 2Health News:For Children With Heart Disease, a Risk of Attention and Behavior Problems 2Health News:Children's Hospital Contributes Genotype Data to Enhance Autism Research Worldwide 2Health News:Children's Hospital Contributes Genotype Data to Enhance Autism Research Worldwide 3Health News:Asthma and smoker's lung: dry airways play a key role 2Health News:Asthma and smoker's lung: dry airways play a key role 3Health News:When poor communication pokes you in the eye 2Health News:The SCOOTER Store Donates Power Scooter to Former NYPD Officer Who Responded to 9/11 2Health News:The SCOOTER Store Donates Power Scooter to Former NYPD Officer Who Responded to 9/11 3
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: